PATENT CLAIM ANALYSIS

Application Number: 15890131
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "282000"]

Abstract:
The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.

Claim (Index 8):
The pharmaceutical composition of  claim 7 , wherein the membrane penetration-enhancing agent is a surfactant, a bile salt, a phospholipid, an alcohol, an enamine, a long-chain amphipathic molecule, a small hydrophobic molecule, sodium or a salicylic acid derivative, a glycerol ester of acetoacetic acid, a cyclodextrin, a medium-chain fatty acid, a chelating agent, an amino acid or salt thereof, an enzyme or combination thereof.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15655669', '14133350', '12645376', '12341696', '13893219']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8760644472953775
- 35 USC 102 Novelty (BERT): 0.5891526153020425
- Combined Prediction Score: 0.847373264096044
- Mean Citation Score: 574.5939099999998
- Max Citation Score: 598.6614400000002
- Similarity Product: 408.47203594871536

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test